{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:00:31Z","timestamp":1794470431145,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8080","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Breast cancer is the second most common cancer globally, with most deaths caused by metastatic disease, often following long periods of clinical dormancy\n                    <jats:sup>1<\/jats:sup>\n                    . Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression. Infections caused by respiratory viruses such as influenza and SARS-CoV-2 trigger both local and systemic inflammation\n                    <jats:sup>2,3<\/jats:sup>\n                    . Here we demonstrate, in mice, that influenza and SARS-CoV-2 infections lead to loss of the pro-dormancy phenotype in breast DCCs in the lung, causing DCC proliferation within days of infection and a massive expansion of carcinoma cells into metastatic lesions within two weeks. These phenotypic transitions and expansions are interleukin-6 dependent. We show that DCCs impair lung T cell activation and that CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells sustain the pulmonary metastatic burden after the influenza infection by inhibiting CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell activation and cytotoxicity. Crucially, these experimental findings align with human observational data. Analyses of cancer survivors from the UK Biobank (all cancers) and Flatiron Health (breast cancer) databases reveal that SARS-CoV-2 infection substantially increases the risk of cancer-related mortality and lung metastasis compared with uninfected cancer survivors. These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer metastasis.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09332-0","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:04:14Z","timestamp":1753887854000},"page":"496-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Respiratory viral infections awaken metastatic breast cancer cells in lungs"],"prefix":"10.1038","volume":"645","author":[{"given":"Shi B.","family":"Chia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-3715","authenticated-orcid":false,"given":"Bryan J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2650-5528","authenticated-orcid":false,"given":"Felipe","family":"Valen\u00e7a-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-5436","authenticated-orcid":false,"given":"Marc","family":"Chadeau-Hyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Guntoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-5019","authenticated-orcid":false,"given":"Hugh","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meher P.","family":"Boorgula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Sreekanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Goodspeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8155-191X","authenticated-orcid":false,"given":"Bennett","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-1715","authenticated-orcid":false,"given":"Marco","family":"De Dominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadym","family":"Zaberezhnyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Schleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3920-7060","authenticated-orcid":false,"given":"Dexiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-5844","authenticated-orcid":false,"given":"Andreia N.","family":"Cadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Petriz-Ota\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Papanicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Beheshti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-3798","authenticated-orcid":false,"given":"Stephen B.","family":"Baylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-8278","authenticated-orcid":false,"given":"Douglas C.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0302-975X","authenticated-orcid":false,"given":"Jenna M.","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-2938","authenticated-orcid":false,"given":"Thomas E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-8163","authenticated-orcid":false,"given":"Roel","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-6507","authenticated-orcid":false,"given":"Julio A.","family":"Aguirre-Ghiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-2225","authenticated-orcid":false,"given":"Mercedes","family":"Rincon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-1976","authenticated-orcid":false,"given":"James","family":"DeGregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"9332_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"9332_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","volume":"38","author":"AH Newton","year":"2016","unstructured":"Newton, A. H., Cardani, A. & Braciale, T. J. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin. Immunopathol. 38, 471\u2013482 (2016).","journal-title":"Semin. Immunopathol."},{"key":"9332_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742941","volume":"12","author":"LY Tan","year":"2021","unstructured":"Tan, L. Y., Komarasamy, T. V. & Rmt Balasubramaniam, V. Hyperinflammatory immune response and COVID-19: a double edged sword. Front. Immunol. 12, 742941 (2021).","journal-title":"Front. Immunol."},{"key":"9332_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1309\/AJCPYO5FSV3UPEXS","volume":"143","author":"A Soni","year":"2015","unstructured":"Soni, A. et al. Breast cancer subtypes predispose the site of distant metastases. Am. J. Clin. Pathol. 143, 471\u2013478 (2015).","journal-title":"Am. J. Clin. Pathol."},{"key":"9332_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan, T. G. & Croucher, P. I. The dormant cancer cell life cycle. Nat. Rev. Cancer 20, 398\u2013411 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"9332_CR6","unstructured":"World Health Organization. Influenza (Seasonal) (WHO, accessed May 2025); https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"9332_CR7","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard (WHO, accessed May 2025); https:\/\/covid19.who.int\/."},{"key":"9332_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore, S. G., Doheny, D. L., Wong, G. L. & Lo, H.-W. IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front. Oncol. 12, 866014 (2022).","journal-title":"Front. Oncol."},{"key":"9332_CR9","doi-asserted-by":"publisher","first-page":"e3002275","DOI":"10.1371\/journal.pbio.3002275","volume":"21","author":"R Ganesan","year":"2023","unstructured":"Ganesan, R. et al. Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape. PLoS Biol. 21, e3002275 (2023).","journal-title":"PLoS Biol."},{"key":"9332_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-013-2575-1","volume":"139","author":"J Hobson","year":"2013","unstructured":"Hobson, J. et al. Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res. Treat. 139, 391\u2013401 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"9332_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo, D. G. et al. CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91\u2013102 (2009).","journal-title":"Cancer Cell"},{"key":"9332_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/jnci\/djad191","volume":"116","author":"U Fedeli","year":"2024","unstructured":"Fedeli, U., Barbiellini Amidei, C., Han, X. & Jemal, A. Changes in cancer-related mortality during the COVID-19 pandemic in the United States. J. Natl Cancer Inst. 116, 167\u2013169 (2024).","journal-title":"J. Natl Cancer Inst."},{"key":"9332_CR13","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578\u201310582 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9332_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nature20609","volume":"540","author":"KL Harper","year":"2016","unstructured":"Harper, K. L. et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature 540, 588\u2013592 (2016).","journal-title":"Nature"},{"key":"9332_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y H\u00fcsemann","year":"2008","unstructured":"H\u00fcsemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58\u201368 (2008).","journal-title":"Cancer Cell"},{"key":"9332_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s43018-022-00424-8","volume":"3","author":"AR Nobre","year":"2022","unstructured":"Nobre, A. R. et al. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nat. Cancer 3, 1165\u20131180 (2022).","journal-title":"Nat. Cancer"},{"key":"9332_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40478-5","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nat. Commun. 14, 4790 (2023).","journal-title":"Nat. Commun."},{"key":"9332_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2022","unstructured":"Di Martino, J. S. et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer 3, 90\u2013107 (2022).","journal-title":"Nat Cancer"},{"key":"9332_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14740\/wjon1419","volume":"13","author":"V Balayan","year":"2022","unstructured":"Balayan, V. & Guddati, A. K. Tumor dormancy: biologic and therapeutic implications. World J. Oncol. 13, 8\u201319 (2022).","journal-title":"World J. Oncol."},{"key":"9332_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz4157","volume":"6","author":"LE Barney","year":"2020","unstructured":"Barney, L. E. et al. Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Sci. Adv. 6, eaaz4157 (2020).","journal-title":"Sci. Adv."},{"key":"9332_CR21","doi-asserted-by":"publisher","unstructured":"Ra\u0161kov\u00e1 M. et al. The role of IL-6 in cancer cell invasiveness and metastasis\u2014overview and therapeutic opportunities. Cells 11, https:\/\/doi.org\/10.3390\/cells11223698 (2022).","DOI":"10.3390\/cells11223698"},{"key":"9332_CR22","doi-asserted-by":"publisher","unstructured":"Gelfo, V. et al. Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21176009 (2020).","DOI":"10.3390\/ijms21176009"},{"key":"9332_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18701-4","volume":"11","author":"M Werner-Klein","year":"2020","unstructured":"Werner-Klein, M. et al. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency. Nat. Commun. 11, 4977 (2020).","journal-title":"Nat. Commun."},{"key":"9332_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/mi.2012.2","volume":"5","author":"O Dienz","year":"2012","unstructured":"Dienz, O. et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 5, 258\u2013266 (2012).","journal-title":"Mucosal Immunol."},{"key":"9332_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","volume":"13","author":"V Poli","year":"1994","unstructured":"Poli, V. et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189\u20131196 (1994).","journal-title":"EMBO J."},{"key":"9332_CR26","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1016\/j.cell.2024.09.016","volume":"187","author":"E Dalla","year":"2024","unstructured":"Dalla, E. et al. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell 187, 6631\u20136648 (2024).","journal-title":"Cell"},{"key":"9332_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fimmu.2019.00611","volume":"10","author":"H-X Tan","year":"2019","unstructured":"Tan, H.-X. et al. Inducible bronchus-associated lymphoid tissues (iBALT) serve as sites of B cell selection and maturation following influenza infection in mice. Front. Immunol. 10, 611 (2019).","journal-title":"Front. Immunol."},{"key":"9332_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791453","volume":"12","author":"AMA R\u00f8mer","year":"2021","unstructured":"R\u00f8mer, A. M. A., Thorseth, M.-L. & Madsen, D. H. Immune modulatory properties of collagen in cancer. Front. Immunol. 12, 791453 (2021).","journal-title":"Front. Immunol."},{"key":"9332_CR29","doi-asserted-by":"publisher","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science https:\/\/doi.org\/10.1126\/science.aao4227 (2018).","DOI":"10.1126\/science.aao4227"},{"key":"9332_CR30","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1073\/pnas.1406259111","volume":"111","author":"M Giordano","year":"2014","unstructured":"Giordano, M. et al. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc. Natl Acad. Sci. USA 111, 11115\u201311120 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9332_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo0981","volume":"7","author":"ME Cook","year":"2022","unstructured":"Cook, M. E. et al. The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses. Sci. Immunol. 7, eabo0981 (2022).","journal-title":"Sci. Immunol."},{"key":"9332_CR32","doi-asserted-by":"publisher","unstructured":"Moore, M. J. et al. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity. eLife https:\/\/doi.org\/10.7554\/eLife.33057 (2018).","DOI":"10.7554\/eLife.33057"},{"key":"9332_CR33","doi-asserted-by":"publisher","first-page":"e0167246","DOI":"10.1371\/journal.pone.0167246","volume":"11","author":"RG Kutty","year":"2016","unstructured":"Kutty, R. G. et al. Dual specificity phosphatase 5 Is essential for T cell survival. PLoS ONE 11, e0167246 (2016).","journal-title":"PLoS ONE"},{"key":"9332_CR34","doi-asserted-by":"publisher","unstructured":"Andreatta, M. et al. A CD4+ T cell reference map delineates subtype-specific adaptation during acute and chronic viral infections. eLife https:\/\/doi.org\/10.7554\/eLife.76339 (2022).","DOI":"10.7554\/eLife.76339"},{"key":"9332_CR35","doi-asserted-by":"crossref","unstructured":"Smith, N. P. et al. Resident memory T cell development is gradual and shows AP-1 gene expression in mature cells. JCI Insight 10, e187381 (2025).","DOI":"10.1172\/jci.insight.187381"},{"key":"9332_CR36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/cdd.2017.102","volume":"24","author":"H Lingel","year":"2017","unstructured":"Lingel, H. et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 24, 1739\u20131749 (2017).","journal-title":"Cell Death Differ."},{"key":"9332_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nri1770","volume":"6","author":"K Honey","year":"2006","unstructured":"Honey, K. Keeping CD4+ T cells under control. Nat. Rev. Immunol. 6, 6\u20137 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"9332_CR38","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1002\/eji.200839154","volume":"39","author":"S Ju","year":"2009","unstructured":"Ju, S. et al. Gadd45b and Gadd45g are important for anti-tumor immune responses. Eur. J. Immunol. 39, 3010\u20133018 (2009).","journal-title":"Eur. J. Immunol."},{"key":"9332_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba4220","volume":"372","author":"T Yue","year":"2021","unstructured":"Yue, T. et al. SLFN2 protection of tRNAs from stress-induced cleavage is essential for T cell\u2013mediated immunity. Science 372, eaba4220 (2021).","journal-title":"Science"},{"key":"9332_CR40","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1080\/15548627.2015.1055439","volume":"11","author":"Y Matsuzawa","year":"2015","unstructured":"Matsuzawa, Y. et al. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy. Autophagy 11, 1052\u20131062 (2015).","journal-title":"Autophagy"},{"key":"9332_CR41","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon III","year":"2020","unstructured":"Dinnon, K. H. III et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"9332_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085 (2020).","journal-title":"Cell"},{"key":"9332_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.592891","volume":"10","author":"F Francescangeli","year":"2020","unstructured":"Francescangeli, F. et al. COVID-19-induced Modifications in the tumor microenvironment: do they affect cancer reawakening and metastatic relapse? Front. Oncol. 10, 592891 (2020).","journal-title":"Front. Oncol."},{"key":"9332_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.813175","volume":"8","author":"I Rahimmanesh","year":"2022","unstructured":"Rahimmanesh, I. et al. Cancer occurrence as the upcoming complications of COVID-19. Front. Mol. Biosci. 8, 813175 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"9332_CR45","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s43018-020-00122-3","volume":"1","author":"L Derosa","year":"2020","unstructured":"Derosa, L. et al. The immuno-oncological challenge of COVID-19. Nat. Cancer 1, 946\u2013964 (2020).","journal-title":"Nat. Cancer"},{"key":"9332_CR46","doi-asserted-by":"crossref","unstructured":"Matthay, M. A. & Luetkemeyer, A. F. IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: who, when, and how? JAMA 326, 483\u2013485 (2021).","DOI":"10.1001\/jama.2021.11121"},{"key":"9332_CR47","first-page":"2281","volume":"327","author":"R Rubin","year":"2022","unstructured":"Rubin, R. Baricitinib is first approved COVID-19 immunomodulatory treatment. JAMA 327, 2281 (2022).","journal-title":"JAMA"},{"key":"9332_CR48","first-page":"954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954\u2013961 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"9332_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3181\/00379727-77-18779","volume":"77","author":"AE Casey","year":"1951","unstructured":"Casey, A. E., Laster, W. R. Jr & Ross, G. L. Sustained enhanced growth of carcinoma EO771 in C57 black mice. Proc. Soc. Exp. Biol. Med. 77, 358\u2013362 (1951).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"9332_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00481-1","volume":"7","author":"BJ Davenport","year":"2022","unstructured":"Davenport, B. J. et al. Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease. npj Vaccines 7, 57 (2022).","journal-title":"npj Vaccines"},{"key":"9332_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16991-2","volume":"11","author":"L Barbier-Torres","year":"2020","unstructured":"Barbier-Torres, L. et al. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat. Commun. 11, 3360 (2020).","journal-title":"Nat. Commun."},{"key":"9332_CR52","doi-asserted-by":"publisher","first-page":"e0150606","DOI":"10.1371\/journal.pone.0150606","volume":"11","author":"Y-RA Yu","year":"2016","unstructured":"Yu, Y.-R. A. et al. A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS ONE 11, e0150606 (2016).","journal-title":"PLoS ONE"},{"key":"9332_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48653-y","volume":"15","author":"M-H Wu","year":"2024","unstructured":"Wu, M.-H. et al. Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies. Nat. Commun. 15, 4444 (2024).","journal-title":"Nat. Commun."},{"key":"9332_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1074-7613(00)80640-8","volume":"9","author":"DD Yang","year":"1998","unstructured":"Yang, D. D. et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575\u2013585 (1998).","journal-title":"Immunity"},{"key":"9332_CR55","doi-asserted-by":"publisher","unstructured":"Valen\u00e7a-Pereira, F. et al. IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca2+ through the noncanonical STAT3 pathway. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2103444118 (2021).","DOI":"10.1073\/pnas.2103444118"},{"key":"9332_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"9332_CR57","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"9332_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2021).","journal-title":"F1000Res."},{"key":"9332_CR59","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2, 100141 (2021).","journal-title":"Innovation (Camb)."},{"key":"9332_CR60","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9332_CR61","doi-asserted-by":"publisher","unstructured":"Franz\u00e9n, O., Gan, L.-M. & Bj\u00f6rkegren, J. L. M. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database (Oxford) https:\/\/doi.org\/10.1093\/database\/baz046 (2019).","DOI":"10.1093\/database\/baz046"},{"key":"9332_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"9332_CR63","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"9332_CR64","unstructured":"Kassambara, A. ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots. https:\/\/cran.r-project.org\/web\/packages\/ggpubr\/index.html (2023)."},{"key":"9332_CR65","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps https:\/\/github.com\/raivokolde\/pheatmap (2019)."},{"key":"9332_CR66","doi-asserted-by":"publisher","first-page":"eabq1533","DOI":"10.1126\/scitranslmed.abq1533","volume":"15","author":"JW Guarnieri","year":"2023","unstructured":"Guarnieri, J. W. et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 15, eabq1533 (2023).","journal-title":"Sci. Transl. Med."},{"key":"9332_CR67","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"9332_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9332_CR69","doi-asserted-by":"publisher","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"9332_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9332_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"9332_CR72","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"9332_CR73","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.4049\/jimmunol.178.12.7563","volume":"178","author":"DM Jelley-Gibbs","year":"2007","unstructured":"Jelley-Gibbs, D. M. et al. Persistent depots of influenza antigen fail to induce a cytotoxic CD8 T cell response. J. Immunol. 178, 7563\u20137570 (2007).","journal-title":"J. Immunol."},{"key":"9332_CR74","doi-asserted-by":"publisher","first-page":"m131","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty, G. D., Gale, C. R., Kivim\u00e4ki, M., Deary, I. J. & Bell, S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ 368, m131 (2020).","journal-title":"BMJ"},{"key":"9332_CR75","doi-asserted-by":"publisher","first-page":"eadf4428","DOI":"10.1126\/scitranslmed.adf4428","volume":"16","author":"NE Allen","year":"2024","unstructured":"Allen, N. E. et al. Prospective study design and data analysis in UK Biobank. Sci. Transl. Med. 16, eadf4428 (2024).","journal-title":"Sci. Transl. Med."},{"key":"9332_CR76","doi-asserted-by":"publisher","unstructured":"Ma, X., Long, L., Moon, S., Adamson, B. J. S. & Baxi, S. S. Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health, SEER, and NPCR. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.16.20037143 (2023).","DOI":"10.1101\/2020.03.16.20037143"},{"key":"9332_CR77","unstructured":"Birnbaum, B. et al. Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research. Preprint at https:\/\/arxiv.org\/abs\/2001.09765 (2020)."},{"key":"9332_CR78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10654-021-00722-y","volume":"36","author":"J Elliott","year":"2021","unstructured":"Elliott, J. et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur. J. Epidemiol. 36, 299\u2013309 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"9332_CR79","doi-asserted-by":"publisher","unstructured":"Ho, D., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. https:\/\/doi.org\/10.18637\/jss.v042.i08 (2011).","DOI":"10.18637\/jss.v042.i08"},{"key":"9332_CR80","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 43, 1130\u20131139 (2005).","journal-title":"Med. Care"},{"key":"9332_CR81","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515\u2013526 (1994).","journal-title":"Biometrika"},{"key":"9332_CR82","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.R-project.org (R Foundation for Statistical Computing, 2021)."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09332-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:01:50Z","timestamp":1757577710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09332-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":82,"journal-issue":{"issue":"8080","published-print":{"date-parts":[[2025,9,11]]}},"alternative-id":["9332"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09332-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4210090\/v1","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.A.-G. is a co-founder, advisory board member and equity holder in HiberCell, a Mount Sinai spin-off that develops cancer recurrence-prevention therapies. He consults for HiberCell and Astrin Biosciences, serves as chief mission advisor for the Samuel Waxman Cancer Research Foundation and has ownership interest in patent number WO2019191115A1\/ EP-3775171-B1. J.D. and M.R. are on the scientific advisory board for Mitotherapeutix. J.C.C. is a cofounder and chief scientific officer of OncoRx Insights. M.C.-H. holds shares in the O-SMOSE company and has no conflict of interest to disclose; consulting activities conducted by the company are independent of the present work. H.M. has consulted for Astra Zeneca relating to the use of monoclonal antibodies in the prevention and treatment of SARS-CoV-2 infection. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}